Unknown PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT01664845

Effects of Metformin, Pegylated Interferon Alpha and Ribavirin for Chronic Hepatitis C With Insulin Resistance

Sponsor: Kaohsiung Veterans General Hospital.

Conditions Chronic Hepatitis c Insulin Resistance

Interventions metformin pegylated-IFN ribavirin

Updated 5 times since 2017 Last updated: Aug 13, 2012 Started: Aug 31, 2012 Primary completion: Aug 31, 2014 Completion: Aug 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2/PHASE3 clinical study on Chronic Hepatitis c and Insulin Resistance, this trial is ongoing. The trial is conducted by Kaohsiung Veterans General Hospital. and has accumulated 5 data snapshots since 2012. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2/PHASE3

Status: Unknown Status → Unknown · Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2_PHASE3
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE2_PHASE3

First recorded

Aug 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Kaohsiung Veterans General Hospital.

Data source: Kaohsiung Veterans General Hospital.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kaohsiung, Taiwan